OSE Immunotherapeutics SA

EPA:OSE.PA

6.05 (EUR) • At close June 5, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) EUR.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q2
Omzet 0.83169.0460.8691.3582.25516.04717.3318.9754.5695.8499.97315.9793.84820.6083.8332.8490.3440.0390.0030.001000000
Kosten van de omzet 0.8310000000-0.00100000000000000000
Brutowinst 069.0460.8691.3582.25516.04717.3318.9754.575.8499.97315.9793.84820.6083.8332.8490.3440.0390.0030.001000000
Brutowinstmarge 01111111111111111111000000
Onderzoek- en ontwikkelingskosten 18.28216.06517.20114.42713.50516.49616.83117.14513.2689.08713.49111.69.0610.639.029.5472.685.3511.9151.0241.7460.3870.0750.0790.6550.655
Algemene en administratieve kosten 2.16302.3883.5742.833.7645.1373.3664.70101.7142.1411.7571.6643.14601.8970.8760.7270.5910.5320.1310.0470.0430.0680.068
Verkoop- en marketingkosten 00-2.2830.7321.3710.8360.6352.468-1.48301.0010.5840.4350.542-0.7900.2740.4050.5141.34300.1350.003000
Verkoop-, algemene en administratieve kosten 3.895.192.864.3064.2014.65.7725.8343.2183.8482.7152.7252.1922.2062.3562.2952.1711.2811.2411.9340.5320.2660.0530.0430.0680.068
Overige kosten -1.639000-0.029-0.049-0.058-0.0470000-2.021-2.458-2.253-1.6570.1750-0.5330-0.1170.0010000
Bedrijfskosten 20.45121.25512.32518.73317.30621.14522.37623.02616.48612.93516.20614.3259.21110.3879.12310.1735.1015.812.6692.9222.1820.6550.1270.1230.7230.723
Bedrijfsresultaat -19.58646.127-9.482-13.504-17.254-6.768-7.078-14.895-11.917-7.086-6.4951.434-5.5110.357-5.289-7.336-4.7914.224-2.621-2.799-2.161-0.654-0.128-0.122-0.722-0.722
Bedrijfsresultaat ratio -23.5690.668-10.911-9.944-7.651-0.422-0.408-1.66-2.608-1.211-0.6510.09-1.4320.503-1.38-2.575-13.927108.308-873.667-2,799000000
Totaal overige inkomsten en kosten netto -1.263-2.606-1.7961.56-1.032-1.741-0.4080.4-0.121-0.122-0.060.2970.133-0.24-0.109-0.0060.0528.108-0.01-0.143-0.017-0.0010.001-0.0010.0050.005
Inkomen voor belasting -20.88357.108-11.278-14.391-18.286-5.168-7.063-14.495-12.038-7.208-6.2541.731-5.37710.084-5.399-7.342-4.74122.333-2.631-2.942-2.178-0.655-0.127-0.123-0.718-0.718
Inkomen voor belasting ratio -25.130.827-12.978-10.597-8.109-0.322-0.408-1.615-2.635-1.232-0.6270.108-1.3970.489-1.409-2.577-13.782572.641-877-2,942000000
Belastingkosten -1.153-0.0670.135-2.532-2.505-3.189-1.701-3.0071.402-4.094-1.0881.2171.991.2071.2361.0020.9012.1730.01100.002-0.0010.001-0.0010.8720.872
Nettowinst -19.7357.175-11.143-11.86-15.781-1.979-5.362-11.488-13.441-3.114-5.1660.514-3.3878.877-4.163-6.34-3.8424.506-2.642-2.942-2.18-0.655-0.127-0.123-0.718-0.718
Nettowinstmarge -23.7420.828-12.823-8.733-6.998-0.123-0.309-1.28-2.942-0.532-0.5180.032-0.880.431-1.086-2.225-11.163628.359-880.667-2,942000000
WPA (Winst Per Aandeel) -0.912.63-0.54-0.64-0.86-0.11-0.29-0.64-0.84-0.21-0.350.035-0.230.57-0.29-0.44-0.252.1-0.27-0.32-0.27-0.09-0.017-0.02-0.09-0.09
Verwaterde WPA -0.912.63-0.54-0.64-0.86-0.11-0.29-0.64-0.84-0.21-0.350.032-0.220.57-0.29-0.44-0.252.1-0.26-0.32-0.27-0.086-0.017-0.016-0.09-0.09
EBITDA -18.22160.637-11.701-11.512-15.801-2.837-4.662-13.468-11.762-6.954-5.872.01-7.0177.553-6.637-8.932-4.7084.24700-0.017-0.0010.001-0.001-0.718-0.718
EBITDA ratio -21.9270.878-13.465-8.477-7.007-0.177-0.269-1.501-2.574-1.189-0.5890.126-1.8240.367-1.732-3.135-13.686108.89700000000